GPC Biotech | Evaluate

December 21, 2010

Who were the cash call kings of 2010?

January 26, 2010

Poniard's happy talk masks dire future for picoplatin

July 03, 2009

CombinatoRx finds that reversing is the way forward

February 18, 2009

GPC hoping to reverse out of trouble

July 22, 2008

Abiraterone data adding weight to Cougar and BTG

May 09, 2008

Wilex and GPC contemplating engagement?

December 18, 2007

The winners and losers of 2007

November 28, 2007

Prostate cancer results power Cougar Biotech's shares

November 27, 2007

Neurocrine unlikely to wake up market with approval

November 22, 2007

VANTAGE EXCLUSIVE - Algeta in deal talks

November 06, 2007

Novacea's Asentar is second set back in two weeks for advanced prostate cancer

Load More